Seminar, Hosted by European College of Neuropsychopharmacology (ECNP) Pharmacogenomics and Transcriptomics Network
Ketamine response in treatment-resistant depression: insights from integrated multi-omics
The University of Western Australia
Abstract
This webinar explores molecular patterns associated with treatment response in depression, focusing on ketamine-treated patients. It examines how baseline metabolomic and transcriptomic profiles can complement clinical information. Using data from 486 patients, including an exploratory ketamine subgroup of 41, the talk considers machine learning, molecular-factor interpretation and individual model explanations. It discusses the limits of current predictive performance and distinguishes response prediction from treatment selection, outlining the evidence needed to translate exploratory findings into clinically useful treatment decisions.